Introduction
============

The cause of non-herpetic limbic encephalitis is often uncertain, but it has recently been suggested that anti-GluR antibody-positive encephalitis may contribute to development of the condition.[@b1-ccrep-6-2013-113]--[@b3-ccrep-6-2013-113] Symptoms such as Parkinsonism and autonomic failure have been reported in non-herpetic limbic encephalitis.[@b4-ccrep-6-2013-113] The lesions present in non-herpetic limbic encephalitis are typically detected by magnetic resonance imaging (MRI) during the early phase. There are several case reports regarding MRI patterns of anti-N-methyl-D-aspartate receptor (NMDAR) and anti-voltage gated potassium channel (VGKC) antibody encephalitis.[@b5-ccrep-6-2013-113],[@b6-ccrep-6-2013-113] However, case reports regarding anti-GluR antibody-positive encephalitis MRI are uncommon, and the relationship between anti-GluR and anti-NMDAR remains unclear. Here, we report two unique cases in males with Parkinsonism and autonomic failure, as well as atypical MRI legions during a later phase.

Case Report
===========

Case 1
------

A 75-year-old previously healthy man developed arthralgia in both distal interphalangeal joints. Forty-eight days later, he experienced hearing loss and tinnitus in the left ear; by day 58, his walking had become unsteady. His cognition gradually became impaired and he was transferred to our hospital 77 days after symptom onset.

His consciousness was stupor with Glasgow coma scale (GCS) at 11 (E3V3M5). Cogwheel rigidity was observed in his bilateral upper limbs, although he was not taking any medication known to cause Parkinsonism. His gait was wide-based and unstable, and nuchal rigidity and Kernig sign were evident. Laboratory examination showed a white cell count of 11,610/μL and a serum reactive C-protein of 0.49 mg/dL. Erythrocyte sedimentation rate was elevated at 65 mm/h. Cartinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) were normal (3.68 ng/mL and 1.2 U/mL, respectively). Electroencephalogram (EEG) showed a diffuse slow wave of 3--4 Hz ([Fig. 1A](#f1-ccrep-6-2013-113){ref-type="fig"}). An MRI during the early clinical phase (day 78 and 95) was unremarkable ([Fig. 2A](#f2-ccrep-6-2013-113){ref-type="fig"}). Single photon emission computed tomography (SPECT) with ^99m^Tc-ethylcysteinate dimer (^99m^Tc-ECD) showed a mild decrease in bilateral frontal and left parietal cerebrocortical blood flow. Chest and abdominal computed tomography (CT) showed no space-occupying lesion.

A lumbar puncture on the first hospital day revealed a cell count of 63/μL (monocyte 48/μL, polynuclear cell 15/μL), an elevated protein level of 72 mg/dL, and a sugar level of 50 mg/dL compared with a serum level of 86 mg/dL. Bacterial and viral cultures of the cerebrospinal (CSF) were negative. Real-time PCR of CSF herpes simplex virus was negative. Interleukin-6 in serum was elevated to 519 pg/mL and in CSF to 911 pg/mL. Autoimmune encephalitis was suspected, and methylprednisolone pulse therapy (1,000 mg/day) was performed twice: at 78--80 days and 85--87 days from onset. His consciousness improved with an increase in GCS to 14 (E4V4M6). Oral prednisolone 60 mg/day (1 mg/kg/day) was initiated, but his consciousness worsened with GCS, dropping to 8 (E2V1M5) at 98 days. Myoclonus appeared in his right upper and lower limbs, and his Parkinsonism worsened. He was not able to sit by himself. Although the deep tendon reflex was normal on the day of admission, it became hyperreflexia, and bilateral Babinski and Chaddock reflexes became positive at 98 days. In an attempt to improve his encephalitis, plasma exchange therapy was performed at 99, 101, 103, and 105 days. This was followed by two doses of methylprednisolone pulse therapy, which gradually improved his symptoms. During the course of symptom improvement, MRI signal abnormalities became evident in the bilateral claustrum, medial of the frontal lobe, with periventricular lesions, at 120 days ([Fig. 2A](#f2-ccrep-6-2013-113){ref-type="fig"}). When he finally returned home after 167 days, his consciousness was alert with GCS of 15 (E4V5M6) and MMSE of 24. Anti-GluRɛ2 and δ2 antibodies were positive in the CSF on the first hospital day, but not in serum after his illness improved ([Table 1](#t1-ccrep-6-2013-113){ref-type="table"}). Anti-VGKC antibody was negative.

Case 2
------

A 52-year-old previously healthy man developed a fever of 39.5 °C and a headache, and four days later gait disturbance appeared accompanied by pollakiuria (approximately 16 times per day) and impaired cognition. He was transferred to our hospital 8 days after symptom onset.

Physical examination showed the absence of abdominal bowel sounds with abdominal distension. Complete urinary retention developed with urethral catheter placement. His consciousness was stupor with GCS at 12 (E4V4M4), and nuchal rigidity and Kernig sign were evident. Serum osmotic pressure was 243 mOsm/kg · H~2~O, serum sodium 118 mEq/L, urinary osmotic pressure 799 mOsm/kg · H~2~O, and urinary sodium 164 mEq/L. His serum vasopressin level increased to 7.9 pg/mL. He was diagnosed with syndrome of inappropriate secretion of antidiuretic hormone (SIADH). CEA and CA19-9 were normal (3.12 ng/mL and 0.8 U/mL, respectively). Abdominal X-ray showed colon expansion and the patient was diagnosed with paralytic ileus. EEG showed polyspike ([Fig. 1B](#f1-ccrep-6-2013-113){ref-type="fig"}). A cranial MRI during the early clinical phase (day 8) showed relatively high intensity of the right posterior cortex ([Fig. 2B](#f2-ccrep-6-2013-113){ref-type="fig"}). The SPECT with ^99m^Tc-ECD showed a severe decrease in diffuse cerebrocortical blood flow. Chest and abdominal CT showed no space-occupying lesion.

A lumbar puncture on the first hospital day revealed a cell count of 68/μL (monocyte 68/μL, polynuclear 0/μL), an elevated protein level of 279 mg/dL, and a sugar level of 50 mg/dL compared with a serum level of 78 mg/dL. Real-time PCR of CSF herpes simplex virus was negative. Because autoimmune encephalitis was also suspected, methylprednisolone pulse therapy (1,000 mg/day) was performed for 3 days from days 9 to 11. His cognition began to improve from day 12, and cranial MRI showed abnormal intensities in the bilateral basal ganglia at day 19 and in the pons at day 57 ([Fig. 2B](#f2-ccrep-6-2013-113){ref-type="fig"}). He was able to care for himself at home with his wife and he resumed working. Anti-GluRɛ2 and δ2 antibodies were positive in CSF on the first hospital day, but not in the serum after his illness improved ([Table 1](#t1-ccrep-6-2013-113){ref-type="table"}).

Discussion
==========

We report two cases of encephalitis presenting with positive anti-GluR antibodies. In addition to disturbance of recognition, Parkinsonism, and myoclonus appeared in case 1 and urinary retention, paralytic ileus, and SIADH appeared in case 2. In case 2, whether pons inflammation involved hyponatremia remains unknown since the abnormal intensity of the MRI appeared after hyponatremia had diminished. EEG showed a slow wave in case 1 ([Fig. 1A](#f1-ccrep-6-2013-113){ref-type="fig"}), but polyspike in case 2 ([Fig. 1B](#f1-ccrep-6-2013-113){ref-type="fig"}). Methylprednisolone pulse therapy was effective, but case 1 required additional plasma exchange therapy. Therefore, there may be several clinical types of anti-GluR antibody-positive encephalitis.

Both cases showed slightly increased MRI intensity during the early phase, which later became evident at 120 days (case 1) and 57 days (case 2). Non-herpetic limbic encephalitis frequently shows MRI abnormalities in the limbic system, but the present cases showed later appearance of abnormal intensities in bilateral claustrum and the pons. The relationship between the symptom and MRI abnormal area of anti-GluR antibody-positive encephalitis may clear the mechanism of encephalitis. These cases demonstrate the importance of considering anti-GluR antibody-positive encephalitis even when there is no abnormal intensity in the cranial MRI in the early phase.
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![(**A**) EEG of case 1 showing widespread continuous slow-wave abnormalities. (**B**) EEG of case 2 showing polyspike.](ccrep-6-2013-113f1){#f1-ccrep-6-2013-113}

![(**A**) Axial fluid attenuated inversion recovery (FLAIR) MR images of case 1. FLAIR MR image at 78 (**a**), 95 (**b**), 120 (**c**), 127 (**d**), and 182 (**e**) days after onset showing high signal intensity in the bilateral claustrum, medial of the anterior lobe, and periventricular legions (arrows) only at 120 and 127 days after onset, which then disappeared 182 days after onset. Mini mental state examination (MMSE). (**B**) FLAIR MR image of case 2 at 8 (**f**), 19 (**g**), 27 (**h**), 57 (**i**), and 91 (**j**) days after onset showing high signal intensity in the bilateral basal ganglia (arrows) at 19 days after onset and in the pons at 57 days after onset, but both disappeared 91 days after onset.](ccrep-6-2013-113f2){#f2-ccrep-6-2013-113}

###### 

Anti-GluR antibodies measured by ELISA.

                                          GluRɛ2-NT2   GluRɛ2-CT1   GluRδ2-NT   GluRδ2-CT
  --------------------------------------- ------------ ------------ ----------- -----------
  Serum                                                                         
   Control                                0.639        0.637        0.721       0.752
   Case 1 (1st hospital day)              0.384        0.389        0.462       0.454
   Case 2 (1st hospital day)              0.316        0.358        0.37        0.34
  CSF                                                                           
   Non-inflammation partial seizure       0.293        0.317        0.395       0.442
   Non-inflammation mental disorder       0.276        0.359        0.373       0.361
   Non-inflammation generalized seizure   0.247        0.352        0.413       0.337
   Case 1 (1st hospital day)              0.840        0.915        1.144       1.143
   Case 2 (1st hospital day)              0.562        0.606        0.742       0.669

**Notes:** Serum control of anti-glutamic acid receptor (anti-GluR) antibodies showed negative control and CSF control showed disease control. In both of case 1 and 2, serum anti-GluR receptor antibodies were negative and CSF anti-GluR antibodies were positive.

**Abbreviation:** CSF, Cerebrospinal fluid.
